Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2127

Title: Improvement in-clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from IMPACT 2.
Authors: Kavanaugh, A
Antoni, C.E.
Krueger, GG
Gladman, D
Birbara, C
Boling, EP
Siegel, EL
Halter, DG
de Vlam, K
Kirkham, B
Beutler, A
Guzzo, C
Zhou, B
Dooley, LT
Mease, Philip J.
Issue Date: 2005
Publisher: WILEY-LISS
Citation: ARTHRITIS AND RHEUMATISM, 52(9). p. S210-S210
Notes: Univ Calif San Diego, La Jolla, CA 92093 USA. Univ Erlangen Nurnberg, Erlangen, Germany. Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA. Toronto Western Hosp, Toronto, ON M5T 2S8, Canada. Univ Massachusetts, Sch Med, Worcester, MA 01605 USA. Rheumatol & Osteoporosis Ctr, Upland, CA USA. Ctr Rheumatol & Bone Res, Wheaton, MD USA. Inst Clin Res, Houston, TX USA. Univ Ctr, Diepenbeek, Belgium. Univ Hosp, Maastricht, Netherlands. Katholieke Univ Leuven Hosp, B-3000 Louvain, Belgium. Guys Hosp, Dept Rheumatol, London SE1 9RT, England. Centocor Inc, Malvern, PA 19355 USA. Swedish Med Ctr, Seattle, WA USA.
URI: http://hdl.handle.net/1942/2127
ISI #: 000232207801015
ISSN: 0004-3591
Category: M
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
N/A503.58 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.